AT66599B - Process for the preparation of medically useful, easily soluble preparations made from natural Franzensbader moor salt. - Google Patents
Process for the preparation of medically useful, easily soluble preparations made from natural Franzensbader moor salt.Info
- Publication number
- AT66599B AT66599B AT66599DA AT66599B AT 66599 B AT66599 B AT 66599B AT 66599D A AT66599D A AT 66599DA AT 66599 B AT66599 B AT 66599B
- Authority
- AT
- Austria
- Prior art keywords
- natural
- franzensbader
- preparation
- salt
- easily soluble
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims description 8
- 238000000034 method Methods 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title claims 4
- OQUFOZNPBIIJTN-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;sodium Chemical compound [Na].OC(=O)CC(O)(C(O)=O)CC(O)=O OQUFOZNPBIIJTN-UHFFFAOYSA-N 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 2
- 229940074439 potassium sodium tartrate Drugs 0.000 description 2
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- -1 alkaline earth metal superoxide Chemical class 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
<Desc/Clms Page number 1>
EMI1.1
Die Erfindung betrifft eine weitere Ausbildung des Verfahrens des Patentes Nr. 64781 insofern, als das natürliche Franzensbader Moorsalz an Stelle des Quellsalzes mit Alkalibzw. Erdalkalisuperoxyd in Gegenwart vom Kalium-Natriumtartrat oder zitronensauren Natrium in der durch das Stammpatent Nr. 64781 geschützten Weise verarbeitet wird. Das Verfahren besteht in folgendem : Ein Gemisch aus 3 Gewichtsteilen natürlichen Franzensbader Moorsalzes, 1 Gewichtsteil Alkali- bzw. Erdalkalisuperoxyds und # Gewichtsteil Kalium-Natriumtartrat oder zitroneusauren Natrium, alle in Pulverform, wird bei 16 bis 200 C solange gerührt und verrieben, bis daraus eine feuchte teigige kompakte Masse entsteht ; diese wird rasch granuliert
EMI1.2
getrocknet und dann gemahlen.
In beiden Fällen erhält man eine körnige Substanz, welche sich in Tablettenform und dgl. gut pressen lässt. Die Tabletten sind haltbar, lösen sich in Wasser schnell und ohne Niederschlag, da die zugesetzten neutralen Salze die Metalle des Moorsalzes in Lösung erhalten ; sie reagieren sauer und dienen als Antiseptikum und Adstringens zu Scheidenspülungen.
**WARNUNG** Ende DESC Feld kannt Anfang CLMS uberlappen**.
<Desc / Clms Page number 1>
EMI1.1
The invention relates to a further development of the method of patent no. 64781 insofar as the natural Franzensbader moor salt in place of the source salt with Alkalibzw. Alkaline earth peroxide is processed in the presence of potassium sodium tartrate or citric acid sodium in the manner protected by the parent patent no. 64781. The process consists of the following: A mixture of 3 parts by weight of natural Franzensbader moor salt, 1 part by weight of alkali or alkaline earth metal superoxide and # part by weight of potassium sodium tartrate or sodium citric acid, all in powder form, is stirred and rubbed at 16 to 200 C until it becomes one moist, doughy compact mass is formed; this is quickly granulated
EMI1.2
dried and then ground.
In both cases, a granular substance is obtained which can be easily pressed into tablet form and the like. The tablets are stable, dissolve quickly and without precipitation in water, since the neutral salts added keep the metals of the moor salt in solution; they are acidic and serve as an antiseptic and astringent for vaginal douching.
** WARNING ** End of DESC field may overlap beginning of CLMS **.
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT66599T | 1910-07-11 | ||
| AT64781T | 1910-07-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT66599B true AT66599B (en) | 1914-09-10 |
Family
ID=25603107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT66599D AT66599B (en) | 1910-07-11 | 1910-07-11 | Process for the preparation of medically useful, easily soluble preparations made from natural Franzensbader moor salt. |
Country Status (1)
| Country | Link |
|---|---|
| AT (1) | AT66599B (en) |
-
1910
- 1910-07-11 AT AT66599D patent/AT66599B/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2722819A1 (en) | CORROSION-INHIBITING COOLANT AND METAL WORKING AGENT | |
| AT66599B (en) | Process for the preparation of medically useful, easily soluble preparations made from natural Franzensbader moor salt. | |
| DE91409T1 (en) | MEDICINE COMPOSITIONS CONTAINING CARRAGEEN. | |
| US2833690A (en) | Magnesium hydroxide suspensions containing sea-plant hydrocolloid | |
| CH640416A5 (en) | ORAL, STABLE, SOLID PHARMACEUTICAL COMPOSITION IN CAPSULE UNIT FOR THE FIGHT AGAINST ANXIETY. | |
| US1183055A (en) | Bromin solution. | |
| DE3706484A1 (en) | Virucides and spermicides containing quaternary ammonium salts | |
| AT93185B (en) | Process for preserving calcium hypochlorite. | |
| AT97145B (en) | Process for the preparation of mercury salts of complex bismuthic acids. | |
| DE1468366A1 (en) | Process for stabilizing stannogluconic acid solutions | |
| AT71175B (en) | Process for the preparation of salizyloyl theobromine. | |
| DE399904C (en) | Process for the production of organic mercury compounds | |
| AT150297B (en) | Process for the preparation of unsymmetrical aromatic arsenic compounds. | |
| DE862341C (en) | Process for the preparation of aqueous solutions of derivatives of p-aminobenzene sulfonamide | |
| AT64781B (en) | Process for the production of medically usable, easily soluble preparations from natural Franzensbad moor salt or spring salt. | |
| AT166482B (en) | ||
| AT147478B (en) | Detergent with disinfecting properties. | |
| AT91678B (en) | Process for the production of cold glue from blood. | |
| DE335911C (en) | Process for the preparation of solid preparations from liver transacids | |
| AT139130B (en) | Process for the production of plant protection products. | |
| AT67784B (en) | Process for the preparation of basic gallocarboxylic acid bismuth. | |
| AT126151B (en) | Pesticides. | |
| AT112104B (en) | Process for maintaining constant the iodine content of solid salt or other mixtures of table salt with iodides. | |
| AT77319B (en) | Process for the preparation of water-soluble compounds of cystine and its derivatives with disinfectants for combating typhoid and other infectious diseases which have their origin in the liver. | |
| AT38550B (en) | Process for the production of a tannin-silver-protein compound which is insoluble in gastric juice and sparingly soluble in intestinal juice. |